Author
Swathi K.1*, Kavya V.2, Vikas S. M.3, Soujanya3, Arun Gowda M. P.3
0 works0 citations
Recent research
- Health & MedicineOpen access
Empagliflozin is a highly selective sodium-glucose cotransporter-2 (SGLT2) inhibitor extensively used in the treatment of type 2 diabetes mellitus and is also indicated for reducing the risk of cardiovascular and renal complications. This review provides a comprehensive overview...
- Health & MedicineOpen access
Empagliflozin is a highly selective sodium-glucose cotransporter-2 (SGLT2) inhibitor extensively used in the treatment of type 2 diabetes mellitus and is also indicated for reducing the risk of cardiovascular and renal complications. This review provides a comprehensive overview...